Skip to content
The People's CodeSearch
Menu

Changes to the Code

S. 5316 · BINSA Act ·

In committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

50 U.S.C. § 4589 Definitions

+21 −3Shown
More for 50 U.S.C. § 4589
Read § 4589Only this section
5 changes the bill asks for here, 5 carried out
  1. Carried out:

    in clause (vii), by striking ; or and inserting a semicolon;

  2. Carried out:

    by redesignating clause (viii) as clause (ix); and

  3. Carried out:

    by inserting after clause (viii) the following:(viii) licensing of a prohibited technology from a covered foreign person; or;

    The section already has a provision under this letter or number, so it would have two.

  4. Carried out:

    in paragraph (7)(A), by adding at the end the following:(vi) Biotechnology, meaning the research, development, manufacturing, or commercialization of— (I) pharmaceutical products (which has the meaning given the term “drug” in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1))); (II) biological …

  5. Carried out:

    in paragraph (10)(A), by adding at the end the following:(vi) Biotechnology, meaning the research, development, manufacturing, or commercialization of— (I) pharmaceutical products (which has the meaning given the term “drug” in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1))); (II) biological …

This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.

§ 4589(4)Covered national security transaction(A)–(B)

Start of § 4589 to (4)(A)(v)(II) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(A)(vi)(vi) (vi)
knowingly directing prohibited transactions or notifiable transactions by foreign persons that the United States person has knowledge at the time of the transaction would constitute an activity described in clause (i), (ii), (iii), (iv), or (v), if engaged in by a United States person;knowingly directing prohibited transactions or notifiable transactions by foreign persons that the United States person has knowledge at the time of the transaction would constitute an activity described in clause (i), (ii), (iii), (iv), or (v), if engaged in by a United States person;
(A)(vii)(vii) (vii)
acquisition of a limited partner or equivalent interest in a venture capital fund, private equity fund, fund of funds, or other pooled investment fund (in each case where the fund is not a United States person) that the United States person has knowledge at the time of the acquisition likely will invest in a person of a country of concern that is in one of the notifiable technology or prohibited technology sectors, and such fund undertakes a transaction that would be a covered national security transaction if undertaken by a United States person;[struck: or]acquisition of a limited partner or equivalent interest in a venture capital fund, private equity fund, fund of funds, or other pooled investment fund (in each case where the fund is not a United States person) that the United States person has knowledge at the time of the acquisition likely will invest in a person of a country of concern that is in one of the notifiable technology or prohibited technology sectors, and such fund undertakes a transaction that would be a covered national security transaction if undertaken by a United States person;
(A)(ix)[struck: (viii)] [inserted: (ix)]
any other transaction identified by the Secretary, in consultation with the appropriate congressional committees and subject to public notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, that is contributing to the military, intelligence, surveillance, or cyber-enabled capabilities of a country of concern.any other transaction identified by the Secretary, in consultation with the appropriate congressional committees and subject to public notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, that is contributing to the military, intelligence, surveillance, or cyber-enabled capabilities of a country of concern.
(B)(B) Exceptions and clarifications(B) Exceptions and clarifications
Subject to regulations prescribed in accordance with this subchapter, the term “covered national security transaction” does not include—Subject to regulations prescribed in accordance with this subchapter, the term “covered national security transaction” does not include—
(B)(i)(i) (i)
any transaction the value of which the Secretary determines is de minimis;any transaction the value of which the Secretary determines is de minimis;

§ 4589(4)Covered national security transaction(B)–(C)

(4)(B)(ii)–(vii) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(B)(vii)(IX)(IX) (IX)
other similar services;other similar services;
(B)(viii)(viii) (viii)
any ordinary or administrative business transaction as may be defined in such regulations; orany ordinary or administrative business transaction as may be defined in such regulations; or
(B)(viii)(viii) [inserted: ]
[inserted: licensing of a prohibited technology from a covered foreign person; or]
(B)(ix)(ix) (ix)
any transaction completed before December 18, 2025.any transaction completed before December 18, 2025.
(C)(C) Ancillary transaction defined(C) Ancillary transaction defined
In this paragraph, the term “ancillary transaction” means, subject to regulations prescribed by the Secretary—In this paragraph, the term “ancillary transaction” means, subject to regulations prescribed by the Secretary—

§ 4589(7)Notifiable technology(A)–(B)

(4)(C)(i)–(7)(A)(iii) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(A)(iv)(iv) (iv)
High-performance computing and supercomputing.High-performance computing and supercomputing.
(A)(v)(v) (v)
Hypersonic systems.Hypersonic systems.
(A)(vi)(vi) [inserted: ]
[inserted: Biotechnology, meaning the research, development, manufacturing, or commercialization of—]
(A)(vi)(I)(I) [inserted: ]
[inserted: pharmaceutical products (which has the meaning given the term “drug” in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1)));]
(A)(vi)(II)(II) [inserted: ]
[inserted: biological products (as defined in section 351(i) of the Public Health Service Act (42 U.S.C. 262(i))); and]
(A)(vi)(III)(III) [inserted: ]
[inserted: therapeutic compounds, including drug discovery platforms, clinical research and development capabilities, biologics manufacturing, and intellectual property and know-how relating to therapeutic compounds.]
(B)(B) Updates(B) Updates
The Secretary, in consultation with the appropriate congressional committees and subject to notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, may prescribe regulations in accordance with this subchapter to—The Secretary, in consultation with the appropriate congressional committees and subject to notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, may prescribe regulations in accordance with this subchapter to—
(B)(i)(i) (i)
define the technical parameters of technologies described in subparagraph (A), as reasonably needed for national security purposes; ordefine the technical parameters of technologies described in subparagraph (A), as reasonably needed for national security purposes; or

§ 4589(10)Prohibited technology(A)–(B)

(7)(B)(ii)–(10)(A)(iii) unchanged

WhereMarkThe Code nowMarkAs the bill would leave it
(A)(iv)(iv) (iv)
High-performance computing and supercomputing.High-performance computing and supercomputing.
(A)(v)(v) (v)
Hypersonic systems.Hypersonic systems.
(A)(vi)(vi) [inserted: ]
[inserted: Biotechnology, meaning the research, development, manufacturing, or commercialization of—]
(A)(vi)(I)(I) [inserted: ]
[inserted: pharmaceutical products (which has the meaning given the term “drug” in section 201(g)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(g)(1)));]
(A)(vi)(II)(II) [inserted: ]
[inserted: biological products (as defined in section 351(i) of the Public Health Service Act (42 U.S.C. 262(i))); and]
(A)(vi)(III)(III) [inserted: ]
[inserted: therapeutic compounds, including drug discovery platforms, clinical research and development capabilities, biologics manufacturing, and intellectual property and know-how relating to therapeutic compounds.]
(B)(B) Updates(B) Updates
The Secretary, in consultation with the appropriate congressional committees and subject to notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, may prescribe regulations in accordance with this subchapter to—The Secretary, in consultation with the appropriate congressional committees and subject to notice and comment in accordance with subchapter II of chapter 5 and chapter 7 of title 5, and not subject to the requirements of section 4559 of this title, may prescribe regulations in accordance with this subchapter to—
(B)(i)(i) (i)
define the technical parameters of technologies described in subparagraph (A), as reasonably needed for national security purposes; ordefine the technical parameters of technologies described in subparagraph (A), as reasonably needed for national security purposes; or

Rest of § 4589 unchanged

Step through the changes